Immunoblotting analysis revealed elevated DAPK1 protein levels in AD brains compared with normal controls (Fig. 11A, B), which is consistent with our prior reports [35, 62], whereas SENP1 levels were reduced in brains of AD patients (Fig. 11A, C). Here, DAPK1 is linked to Alzheimer disease.